Division of Gynecologic Oncology, Department of Obstetrics, Gynecology, and Women's Health, University of Minnesota, Minneapolis, Minnesota.
Program in Health Disparities Research, Department of Family Medicine and Community Health, University of Minnesota Medical School, Minneapolis, Minnesota.
Cancer. 2022 Jul 15;128(14):2753-2759. doi: 10.1002/cncr.34213. Epub 2022 May 16.
Cervical cancer screening is recommended for those with a cervix who are 21 to 65 years old, with specific timelines being dependent on individual risk. This study compared rates of ever undergoing Papanicolaou (Pap) testing at the intersection of self-reported sexual minority (SM) status and race/ethnicity.
Data from the National Health Interview Survey (2015 and 2018) were used to examine cervical cancer screening disparities. Natal females without a history of hysterectomy who were 21 to 65 years old and had reported their sexual orientation and Pap testing history were included. Demographic and health characteristics were summarized with descriptive statistics. To adjust for differences in confounding variables between groups, propensity score-based inverse probability of treatment weighting (IPTW) was performed. IPTW-adjusted multivariable logistic regression models estimated odds of ever undergoing a Pap test by sexual orientation alone and with race/ethnicity (non-Hispanic White, non-Hispanic Black, and Hispanic).
SM persons (n = 877) had significantly reduced odds of ever undergoing Pap testing (odds ratio, 0.54; 95% confidence interval, 0.42-0.70) in comparison with heterosexual persons (n = 17,760). When the intersection of sexual orientation and race/ethnicity was considered, non-Hispanic White SM participants and Hispanic SM participants had reduced odds of ever undergoing Pap testing in comparison with non-Hispanic White heterosexual participants. No significant differences were observed between non-Hispanic White heterosexual participants and participants of non-Hispanic Black SM or Hispanic heterosexual identities.
SM participants were significantly less likely to have ever undergone a Pap test in comparison with heterosexual participants, with Hispanic SM participants having the lowest uptake. Future studies should further examine the roles of systemic discrimination and other key drivers of these disparities.
建议有子宫的 21 至 65 岁人群进行宫颈癌筛查,具体时间取决于个体风险。本研究比较了报告为性少数群体(SM)的人群与种族/族裔之间接受巴氏涂片(Pap)检测的比率。
利用国家健康访谈调查(2015 年和 2018 年)的数据,研究了宫颈癌筛查的差异。排除有子宫切除术史的女性,年龄在 21 至 65 岁之间,报告过性取向和巴氏涂片检测史的女性被纳入研究。使用描述性统计方法总结人口统计学和健康特征。为了调整组间混杂变量的差异,采用倾向评分逆概率治疗加权(IPTW)。采用 IPTW 调整的多变量逻辑回归模型,估计仅基于性取向和同时基于性取向和种族/族裔(非西班牙裔白人、非西班牙裔黑人、西班牙裔)的接受巴氏涂片检测的可能性。
与异性恋者(n=17760)相比,SM 人群(n=877)接受巴氏涂片检测的可能性显著降低(比值比,0.54;95%置信区间,0.42-0.70)。当考虑性取向和种族/族裔的交叉点时,与非西班牙裔白人异性恋参与者相比,非西班牙裔白人 SM 参与者和西班牙裔 SM 参与者接受巴氏涂片检测的可能性降低。非西班牙裔白人异性恋参与者与非西班牙裔黑人 SM 参与者或西班牙裔异性恋参与者之间未观察到显著差异。
与异性恋参与者相比,SM 参与者接受巴氏涂片检测的可能性显著降低,其中西班牙裔 SM 参与者的参与率最低。未来的研究应进一步探讨系统性歧视和其他导致这些差异的关键因素的作用。